These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 10928141)

  • 1. Fas-Fas ligand pathway does not actively work in extrahepatic bile duct carcinoma.
    Ito Y; Takeda T; Sakon M; Tsujimoto M; Matsuura N
    Anticancer Res; 2000; 20(3B):1999-2003. PubMed ID: 10928141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and clinical significance of the G1-S modulators in carcinoma of the extrahepatic bile duct.
    Ito Y; Takeda T; Sakon M; Monden M; Tsujimoto M; Matsuura N
    Anticancer Res; 2000; 20(1A):337-44. PubMed ID: 10769677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of Ki-67 and p53 antigen expression in carcinomas of bile duct and gallbladder.
    Shrestha ML; Miyake H; Kikutsuji T; Tashiro S
    J Med Invest; 1998 Aug; 45(1-4):95-102. PubMed ID: 9864969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequent loss of Fas expression and function in human lung tumours with overexpression of FasL in small cell lung carcinoma.
    Viard-Leveugle I; Veyrenc S; French LE; Brambilla C; Brambilla E
    J Pathol; 2003 Oct; 201(2):268-77. PubMed ID: 14517844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and clinical implications of bcl-2 in extrahepatic bile duct carcinoma: its relationship with biological features.
    Ito Y; Takeda T; Sakon M; Tsujimoto M; Matsuura N
    Anticancer Res; 2000; 20(5C):3891-5. PubMed ID: 11268472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Up-regulation of fas ligand at early stages and down-regulation of Fas at progressed stages of intrahepatic cholangiocarcinoma reflect evasion from immune surveillance.
    Shimonishi T; Isse K; Shibata F; Aburatani I; Tsuneyama K; Sabit H; Harada K; Miyazaki K; Nakanuma Y
    Hepatology; 2000 Oct; 32(4 Pt 1):761-9. PubMed ID: 11003620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical analysis of apoptosis-related factors in lining epithelium of radicular cysts.
    Suzuki T; Kumamoto H; Kunimori K; Ooya K
    J Oral Pathol Med; 2005 Jan; 34(1):46-52. PubMed ID: 15610406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of Fas and Fas ligand in the testes and testicular germ cell tumors: an immunohistochemical study.
    Sugihara A; Saiki S; Tsuji M; Tsujimura T; Nakata Y; Kubota A; Kotake T; Terada N
    Anticancer Res; 1997; 17(5B):3861-5. PubMed ID: 9427793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. c-FLIP expression in bladder urothelial carcinomas: its role in resistance to Fas-mediated apoptosis and clinicopathologic correlations.
    Korkolopoulou P; Goudopoulou A; Voutsinas G; Thomas-Tsagli E; Kapralos P; Patsouris E; Saetta AA
    Urology; 2004 Jun; 63(6):1198-204. PubMed ID: 15183989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fas/Fas ligand system and apoptosis induction in testicular carcinoma.
    Schmelz HU; Abend M; Kraft K; Hauck EW; Weidner W; Van Beuningen D; Sparwasser C
    Cancer; 2002 Jul; 95(1):73-81. PubMed ID: 12115319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of p53 and Ki-67 expression in resected or biopsy specimens of bile duct carcinoma.
    Murakami M; Sasaki T; Kuwada Y; Yamasaki S; Kuwahara K; Chayama K
    Oncol Rep; 2003; 10(5):1091-6. PubMed ID: 12883663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apoptosis, proliferation, and Fas (APO-1, CD95)/Fas ligand expression in medullary carcinoma of the breast.
    Yakirevich E; Maroun L; Cohen O; Izhak OB; Rennert G; Resnick MB
    J Pathol; 2000 Oct; 192(2):166-73. PubMed ID: 11004692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carcinoma of the ampulla of Vater associated with or without adenoma: a clinicopathologic analysis of 198 cases with reference to p53 and Ki-67 immunohistochemical expressions.
    Takashima M; Ueki T; Nagai E; Yao T; Yamaguchi K; Tanaka M; Tsuneyoshi M
    Mod Pathol; 2000 Dec; 13(12):1300-7. PubMed ID: 11144926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apoptosis and Fas-ligand expression correlate to the histopathological grade of gastric smooth muscle tumors.
    Liu Y; Chen C; Chen C; Hsieh H; Chang C; Shyu J; Yen C; Harn H
    J Surg Res; 2001 Feb; 95(2):92-8. PubMed ID: 11162031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Susceptibility of cholangiocarcinoma cells to parthenolide-induced apoptosis.
    Kim JH; Liu L; Lee SO; Kim YT; You KR; Kim DG
    Cancer Res; 2005 Jul; 65(14):6312-20. PubMed ID: 16024633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of Fas and Fas-related molecules in human hepatocellular carcinoma.
    Lee SH; Shin MS; Lee HS; Bae JH; Lee HK; Kim HS; Kim SY; Jang JJ; Joo M; Kang YK; Park WS; Park JY; Oh RR; Han SY; Lee JH; Kim SH; Lee JY; Yoo NJ
    Hum Pathol; 2001 Mar; 32(3):250-6. PubMed ID: 11274632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency of apoptosis of tumor-infiltrating lymphocytes induced by fas counterattack in human colorectal carcinoma and its correlation with prognosis.
    Okada K; Komuta K; Hashimoto S; Matsuzaki S; Kanematsu T; Koji T
    Clin Cancer Res; 2000 Sep; 6(9):3560-4. PubMed ID: 10999744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of Fas expression and augmentation of Fas/Fas ligand-mediated apoptosis by the synthetic retinoid CD437 in human lung cancer cells.
    Sun SY; Yue P; Hong WK; Lotan R
    Cancer Res; 2000 Nov; 60(22):6537-43. PubMed ID: 11103825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential activation of the Fas/CD95 pathway by Ad-p53 in human gliomas.
    Cerrato JA; Khan T; Koul D; Lang FF; Conrad CA; Yung WK; Liu TJ
    Int J Oncol; 2004 Feb; 24(2):409-17. PubMed ID: 14719118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apoptosis-related proteins (Fas, Fas ligand, bcl-2 and p53) in different types of human breast tumors.
    Ben-Hur H; Mordechay E; Halperin R; Gurevich P; Zandbank J; Herper M; Zusman I
    Oncol Rep; 2002; 9(5):977-80. PubMed ID: 12168058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.